References
1 Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the
immunocompromised host. Nat Rev Microbiol 2021. 19 :
759-773.
2 Guo RF, Gebreab FH, Tang EH et al. Cutaneous ulcer as leading
symptom of systemic cytomegalovirus infection. Case Rep Infect
Dis 2015. 2015 : 723962.
3 Kasuya A, Kaneko Y, Enomoto N et al. Simultaneous reactivation
of cytomegalovirus in an adult patient with varicella. J Dermatol2015. 42 : 658-659.
4 Hioki T, Takama H, Makita S et al. Cytomegalovirus reactivation
accompanied by varicella zoster virus reactivation or reinfection in an
adult patient of multiple myeloma during bortezomib therapy. J
Dermatol 2018. 45 : 108-109.
5 Qi Z, Sun Y, Li J et al. Severe pulmonary co-infection with
varicella-zoster virus, Pneumocystis jirovecii and Cytomegalovirus: a
case report. J Int Med Res 2022. 50 : 3000605211070759.
6 Aringer M, Costenbader K, Daikh D et al. 2019 European League
Against Rheumatism/American College of Rheumatology Classification
Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol2019. 71 : 1400-1412.
7 Moon JH, Kim EA, Lee KS et al. Cytomegalovirus pneumonia:
high-resolution CT findings in ten non-AIDS immunocompromised patients.Korean J Radiol 2000. 1 : 73-78.
8 Kim JS, Ryu CW, Lee SI et al. High-resolution CT findings of
varicella-zoster pneumonia. AJR Am J Roentgenol 1999.172 : 113-116.
9 Kimura N, Urabe K, Furue M. Recurrent Varicella in a Patient with
Systemic Lupus Erythematosus Treated with Immunosuppressants.Nishinihon J Dermatol 2018. 80 : 354-357.
10 Rondaan C, van Leer CC, van Assen S et al. Longitudinal
analysis of varicella-zoster virus-specific antibodies in systemic lupus
erythematosus: No association with subclinical viral reactivations or
lupus disease activity. Lupus 2018. 27 : 1271-1278.
11 Ohtaki S, Kodama H, Hondo R, Kurata T. Activation of cytomegalovirus
infection in immunosuppressed cynomolgus monkeys inoculated with
varicella-zoster virus. Acta Pathol Jpn 1986. 36 :
1537-1552.